Neonatal Fc receptor induces intravenous immunoglobulin growth suppression in Langerhans cell histiocytosis-Reference-Cited by-同舟云学术

Neonatal Fc receptor induces intravenous immunoglobulin growth suppression in Langerhans cell histiocytosis

Published:2021-01-26 Issue:3 Volume:71 Page:191-198
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:Pathology International

Author:

Nabeshima Yuka¹,Kataoka Tatsuki R.¹²,Ueshima Chiyuki¹,Saito Narumi¹,Hirata Masahiro¹,Takeuchi Yasuhide¹³^ORCID,Takei Yusuke¹⁴,Moriyoshi Koki¹⁵,Ono Kazuo⁶,Haga Hironori¹

Affiliation:

1. Department of Diagnostic Pathology Kyoto University Hospital Kyoto Japan

2. Department of Molecular Diagnostic Pathology Iwate Medical University Iwate Japan

3. Clinical Bio Resource Center Kyoto University Hospital Kyoto Japan

4. Department of Diagnostic Pathology Saiseikai Noe Hospital Osaka Japan

5. Department of Diagnostic Pathology Kyoto Medical Center Kyoto Japan

6. Department of Pathology Japan Red Cross Society Wakayama Medical Center Wakayama Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pin.13068

Reference36 articles.

1. Langerhans Cell Histiocytosis: A Clinicopathologic Review and Molecular Pathogenetic Update

2. Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment

3. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

4. Treatment of neurodegenerative CNS disease in Langerhans cell histiocytosis with a combination of intravenous immunoglobulin and chemotherapy

5. Fifteen years of treatment with intravenous immunoglobulin in central nervous system Langerhans cell histiocytosis